Spahn, J., Peng, J., Lorenzana, E., Kan, D., Hunsaker, T., Segal, E., . . . Hatzivassiliou, G. (2015). Improved anti-tumor immunity and efficacy upon combination of the IDO1 inhibitor GDC-0919 with anti-PD-l1 blockade versus anti-PD-l1 alone in preclinical tumor models. J Immunother Cancer.
Παραπομπή Chicago StyleSpahn, Jessica, et al. "Improved Anti-tumor Immunity and Efficacy Upon Combination of the IDO1 Inhibitor GDC-0919 With Anti-PD-l1 Blockade Versus Anti-PD-l1 Alone in Preclinical Tumor Models." J Immunother Cancer 2015.
Παραπομπή MLASpahn, Jessica, et al. "Improved Anti-tumor Immunity and Efficacy Upon Combination of the IDO1 Inhibitor GDC-0919 With Anti-PD-l1 Blockade Versus Anti-PD-l1 Alone in Preclinical Tumor Models." J Immunother Cancer 2015.